Literature DB >> 6210080

Regional distribution of neuromedin K and neuromedin L in rat brain and spinal cord.

N Minamino, H Masuda, K Kangawa, H Matsuo.   

Abstract

Neuromedin K and neuromedin L are novel mammalian tachykinins isolated from porcine spinal cord. We have developed a highly sensitive radioimmunoassay for neuromedin K. Since the radioimmunoassay for neuromedin K has significant crossreactivity with neuromedin L and substance P, we can simultaneously determine the tissue concentrations of neuromedin K, neuromedin L and substance P after separation of the tissue extracts by reverse phase high performance liquid chromatography. Substance P is found to be the most abundant mammalian tachykinin in every brain region. The ratio of the concentration of substance P to neuromedin K is small in cerebral cortex and large in medulla-pons, while that of substance P to neuromedin L is rather constant in a range of 2.0-2.5. In spinal cord, dorsal half contains more neuromedin K and L than ventral half as is the case with substance P. These results indicate that both neuromedin K and L are endogenous mammalian tachykinins with specific physiological functions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210080     DOI: 10.1016/0006-291x(84)91019-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Substance P as a potent stimulator of sneeze responses in experimental allergic rhinitis of guinea pigs.

Authors:  T Imamura; T Kambara
Journal:  Agents Actions       Date:  1992-11

2.  Development of substance P and neurokinin A immunoreactivity in ganglia supplying nerves to the submandibular glands of the rat.

Authors:  E Virta; H Uusitalo
Journal:  Histochemistry       Date:  1993-10

3.  Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding.

Authors:  A E Kelley; M Cador; L Stinus; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons.

Authors:  N Lindefors; S Brené; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

5.  Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.

Authors:  C Tschöpe; P Picard; J Culman; A Prat; K Itoi; D Regoli; T Unger; R Couture
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P.

Authors:  C J Dalsgaard; A Haegerstrand; E Theodorsson-Norheim; E Brodin; T Hökfelt
Journal:  Histochemistry       Date:  1985

Review 7.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10

8.  Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin.

Authors:  R Laufer; U Wormser; Z Y Friedman; C Gilon; M Chorev; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.